PEAR shares soared 10% today. A look at what's happening:

Shares of Pear Therapeutics Inc - Class A (PEAR) are trading 10% higher at a price of $1.875 at the time of this writing. While the Health Care sector is having a bullish day in general, the company is outrunning it's peers.

Some recent news moving the stock:

-Pear Therapeutics and SelectHealth have announced coverage for a FDA-authorized prescription digital therapeutic for the treatment of opioid use disorder.
-Pear Therapeutics has laid off 9% of its workforce and is guiding for $15 million in revenue.

Pear Therapeutics Inc - Class A has been trading between a 52-week high of $14.6 and a 52-week low of $1.34. The stock has a market cap of $260 Million.

Pear Therapeutics, is the parent company of Pear Therapeutics (US), Inc. Pear is the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs). Pear aims to redefine care through the widespread use of clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers.